Literature DB >> 24763828

Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma.

Malek Hossein Asadi1, Ali Derakhshani, Seyed Javad Mowla.   

Abstract

Nucleostemin (NS) is a nucleolar protein involved in stem cell (SC) self-renewal by controlling cell cycle progression. In addition to SCs, NS is also expressed in some highly proliferating cells including several adult stem cells and cancer cell lines. NS knock-down in different cell lines demonstrated its cell type-dependent function in arresting cell cycle in either G1 or G2/M phases. Here, we have evaluated the expression of NS and iPS genes in 36 gastric cancer and their matched marginal nontumor tissues by means of real-time polymerase chain reaction (RT-PCR). We have also examined a potential causative role of NS in gastric tumorigenesis by suppressing its expression in a gastric cancer cell line, AGS. Our data revealed that NS expression level is much higher in tumor tissues (p = 0.046), especially in high-grade ones (p < 0.001), whereas the expression of Klf4 and Sox2 is downregulated in tumor tissues compared to marginal nontumor samples (p < 0.001). Furthermore, NS suppression in the AGS cell line caused some morphological alterations, a cell cycle arrest at G1 phase, and an upregulation of iPS genes: Nanog, Sox2, and Klf4. Based on our results, NS overexpression seems to have a causative role in gastric tumorigenesis and/or progression, and it could be considered as a potential tumor marker for diagnosis, molecular classification, and molecular therapy of gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24763828     DOI: 10.1007/s13277-014-1966-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.

Authors:  Robert Y L Tsai; Ronald D G McKay
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  The homologous putative GTPases Grn1p from fission yeast and the human GNL3L are required for growth and play a role in processing of nucleolar pre-rRNA.

Authors:  Xianming Du; Malireddi R K Subba Rao; Xue Qin Chen; Wei Wu; Sundarasamy Mahalingam; David Balasundaram
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

3.  Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.

Authors:  Mu-Shui Dai; Xiao-Xin Sun; Hua Lu
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

4.  Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors.

Authors:  Mahshid Malakootian; Seyed Javad Mowla; Hooshang Saberi; Malek Hossein Asadi; Yaser Atlasi; Afsaneh Malekzadeh Shafaroudi
Journal:  Mol Carcinog       Date:  2010-09       Impact factor: 4.784

5.  Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow.

Authors:  Wael Kafienah; Sanjay Mistry; Christopher Williams; Anthony P Hollander
Journal:  Stem Cells       Date:  2005-11-10       Impact factor: 6.277

6.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.

Authors:  Benjamin D Rowland; René Bernards; Daniel S Peeper
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

7.  OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.

Authors:  Malek H Asadi; Seyed J Mowla; Fardin Fathi; Ahmad Aleyasin; Jamshid Asadzadeh; Yaser Atlasi
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

8.  Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression.

Authors:  Masashi Kanai; Daoyan Wei; Qiang Li; Zhiliang Jia; Jaffer Ajani; Xiangdong Le; James Yao; Keping Xie
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

9.  Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.

Authors:  P Nikpour; S J Mowla; S M Jafarnejad; U Fischer; W A Schulz
Journal:  Cell Prolif       Date:  2009-08-25       Impact factor: 6.831

10.  Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.

Authors:  Gongyuan Zhang; Qiao Zhang; Qinxian Zhang; Lei Yin; Shenglei Li; Kuisheng Cheng; Yunhan Zhang; Honghui Xu; Weidong Wu
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-13       Impact factor: 4.553

View more
  5 in total

1.  OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.

Authors:  Malek Hossein Asadi; Khosrow Khalifeh; Seyed Javad Mowla
Journal:  J Neurooncol       Date:  2016-09-01       Impact factor: 4.130

2.  Guanine nucleotide binding protein-like 3 is a potential prognosis indicator of gastric cancer.

Authors:  Jing Chen; Shuang Dong; Jiangfeng Hu; Bensong Duan; Jian Yao; Ruiyun Zhang; Hongmei Zhou; Haihui Sheng; Hengjun Gao; Shunlong Li; Xianwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  SOX2 inhibits metastasis in gastric cancer.

Authors:  Yansu Chen; Yefei Huang; Liwen Zhu; Minjuan Chen; Yulin Huang; Jianbing Zhang; Song He; Aiping Li; Rui Chen; Jianwei Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-09       Impact factor: 4.553

4.  Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: insights into the action mechanisms using quantitative proteomics.

Authors:  Sandra Montalvo-Quiros; Guillermo Aragoneses-Cazorla; Laura Garcia-Alcalde; María Vallet-Regí; Blanca González; Jose L Luque-Garcia
Journal:  Nanoscale       Date:  2019-03-07       Impact factor: 7.790

5.  Gene expression profiling of NB4 cells following knockdown of nucleostemin using DNA microarrays.

Authors:  Xiaoli Sun; Yu Jia; Yuanyu Wei; Shuai Liu; Baohong Yue
Journal:  Mol Med Rep       Date:  2016-05-05       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.